BioCryst 公司将以 7 亿美元收购 Astria Therapeutics 公司

路透中文
Oct 14
BioCryst 公司将以 7 亿美元收购 Astria <a href="https://laohu8.com/S/LENZ">Therapeutics</a> 公司

路透社10月14日 - BioCryst Pharmaceuticals BCRX.O周二表示,该公司将以现金加股票的方式收购Astria Therapeutics ATXS.O,交易价值约为7亿美元,以扩大其罕见病治疗产品组合。

(为便利非英文母语者,路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误,或未能包含所需语境,路透不保证自动化翻译文本的准确性,仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失,路透不承担任何责任。)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10